Subjective Cognitive Decline (SCD)
0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Jerusalem PharmaceuticalsIsrael - Ramallah
2 programsCog Fun Ageing interventionN/A1 trial
Cog Fun Ageing interventionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
Jerusalem PharmaceuticalsCog Fun Ageing intervention
Jerusalem PharmaceuticalsCog Fun Ageing intervention
Clinical Trials (2)
Total enrollment: 70 patients across 2 trials
Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline
Start: Nov 2024Est. completion: Aug 202540 patients
N/ARecruiting
Cog-Fun Ageing Participation-centered, Health Promotion for Older Adults
Start: Apr 2024Est. completion: Apr 202530 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 70 patients
1 companies competing in this space